Company / Working Capital per Share
Beam Therapeutics Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$11.52
FY2025
5-year range
$8.32 / $15.49
FY2021-FY2025
Trend
+38.4%
vs FY2024
Sector context
#41 of 210
Health Care
What the data says
Beam Therapeutics Inc.'s working capital per share of $11.52 is higher than 80% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 7 years, ranging from $8.32 in FY2024 to $28.12 in FY2020.
Based on SEC 10-K filings.
11.52 in FY2025 with a 5-year CAGR of -16.3%. Top quartile in the Health Care sector.
Declined from $12.32 to $11.52 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- -16.3%
- 10-Year CAGR
- -
Sector benchmark
-92.2% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 38.4% year-over-year.
- Ranks #41 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.52 | +38.4% |
| FY2024 | $8.32 | -32.4% |
| FY2023 | $12.32 | +1.0% |
| FY2022 | $12.20 | -21.3% |
| FY2021 | $15.49 | -44.9% |
| FY2020 | $28.12 | +178.5% |
| FY2019 | $10.09 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026